English(EN) PRISMATIC : Prescription Risk Inspection System for Multi-Agent Treatment Interaction in Clinical Decision-Making

新的多智能体系统PRISMATIC旨在减少临床处方错误

作者 PulseAugur 编辑部 · [1 个来源] · 2026-10-15 04:00

研究人员开发了PRISMATIC，一个新颖的多智能体系统，旨在改善临床决策并减少多病患者的处方错误。该系统利用专门的智能体在共享黑板上协作，以生成和优化治疗计划，并结合自适应协调机制进行长期学习和短期冲突解决。使用MIMIC-IV数据库进行的实验表明，与现有的大型语言模型基线相比，PRISMATIC显著减少了药物冲突并提高了治疗一致性。 AI

影响通过减少复杂病例中的药物错误，可能带来更安全的患者护理。

排序理由详细介绍临床决策新系统的研究论文。[lever_c_demoted from research: ic=1 ai=1.0]

在 arXiv cs.CL 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 16 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; 详细介绍临床决策新系统的研究论文。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: paper, safety, product; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: High; Clearly on-topic for AI-industry coverage.
Story freshness: Breaking (< 6h); Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。

报道来源 [1]

arXiv cs.CL TIER_1 English(EN) · Ziyang Ling, Shuyu Lu, Ziyi Chen · 2026-10-15 04:00

PRISMATIC：临床决策中多主体治疗相互作用的处方风险检查系统

arXiv:2610.19762v1 Announce Type: new Abstract: Medical prescribing errors for multimorbid patients, who require complex drug regimens, are a major patient safety concern. These errors often stem from fragmented decision-making across medical specialties, a critical coordination …

本文如何被排名

报道来源 [1]

PRISMATIC：临床决策中多主体治疗相互作用的处方风险检查系统

相关实体

相关话题